Work

Advancing Virtual Reality-Based Attentional Bias as a Biomarker for Tobacco Use Disorder, San Diego, California, 2024-2025

Year: 2026

Type: dataset

Abstract: The Varenicline Virtual Reality Study includes daily cigarette users, ages 22+, from the San Diego community. Participants are assessed on the VR Nicotine Cue Exposure paradigm then pseudo-randomized (stratified on age and sex) to receive varenicline (target dose 1mg twice daily) or placebo (target n per group=100; target total N=200). Following eight days of titration, participants are assessed again on the VR Nicotine Cue Exposure paradigm.

Source: ICPSR Data Holdings

DOI: 10.3886/icpsr39816

Authors: Courtney, Kelly E., University of California-San Diego

Institution: University of California San Diego

Language: English

Topic: Smoking Behavior and Cessation

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7154173031

Cites:

Cited by:

Related to: 10